Evidence map›Paper›PMID 40087786›Full record

ArticleInternational journal of health geographics2025

Different environmental factors predict the occurrence of tick-borne encephalitis virus (TBEV) and reveal new potential risk areas across Europe via geospatial models.

Patrick H Kelly, Rob Kwark, Harrison M Marick, Julie Davis, James H Stark, Harish Madhava, Gerhard Dobler, Jennifer C Moïsi

Abstract read
In one paragraph

Article in International journal of health geographics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Targeted monitoring informed by mapping the ongoing spread of tick-borne encephalitis virus, the Netherlands.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Occurrence and prevalence of host-seekingCurrent research in parasitology & vector-borne diseases · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Patrick H KellyVaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, Pfizer, Inc., 66 Hudson Yards Blvd E, New York City, NY, USA. patrick.kelly2@pfizer.com.
Rob KwarkTiber Solutions, Fairfax, VA, USA.
Harrison M MarickTiber Solutions, Fairfax, VA, USA.
Julie DavisClarivate Analytics, Phoenix, AZ, USA.
James H StarkVaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, Cambridge, MA, USA.
Harish MadhavaVaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, London, UK.
Gerhard DoblerBundeswehr Institute for Microbiology, National TBEV Consultant Laboratory, 80937, Munchen, Germany.
Jennifer C MoïsiVaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTick-borne encephalitis (TBE) is the most serious tick-borne viral disease in Europe. Identifying TBE risk areas can be difficult due to hyper focal circulation of the TBE virus (TBEV) between mammals and ticks. To better define TBE hazard risks and elucidate regional-specific environmental factors that drive TBEV circulation, we developed two machine-learning (ML) algorithms to predict the habitat suitability (maximum entropy), and occurrence of TBEV (extreme gradient boosting) within distinct European regions (Central Europe, Nordics, and Baltics) using local variables of climate, habitat, topography, and animal hosts and reservoirs.

methodsGeocoordinates that reported the detection of TBEV in ticks or rodents and anti-TBEV antibodies in rodent reservoirs in 2000 or later were extracted from published and grey literature. Region-specific ML models were defined via K-means clustering and trained according to the distribution of extracted geocoordinates relative to explanatory variables in each region. Final models excluded colinear variables and were evaluated for performance.

results521 coordinates (455 ticks; 66 rodent reservoirs) of TBEV occurrence (2000-2022) from 100 records were extracted for model development. The models had high performance across regions (AUC: 0.72-0.92). The strongest predictors of habitat suitability and TBEV occurrence in each region were associated with different variable categories: climate variables were the strongest predictors of habitat suitability in Central Europe; rodent reservoirs and elevation were strongest in the Nordics; and animal hosts and land cover contributed most to the Baltics. The models predicted several areas with few or zero reported TBE incidence as highly suitable (≥ 60%) TBEV habitats or increased probability (≥ 25%) of TBEV occurrence including western Norway coastlines, northern Denmark, northeastern Croatia, eastern France, and northern Italy, suggesting potential capacity for locally-acquired autochthonous TBEV infections or possible underreporting of TBE cases based on reported human surveillance data.

conclusionsThis study shows how varying environmental factors drive the occurrence of TBEV within different European regions and identifies potential new risk areas for TBE. Importantly, we demonstrate the utility of ML models to generate reliable insights into TBE hazard risks when trained with sufficient explanatory variables and to provide high resolution and harmonized risk maps for public use.

Indexed as

Encephalitis, Tick-BorneEncephalitis Viruses, Tick-BorneEnvironmentAnimalsDisease ReservoirsEcosystemEuropeHumansRisk FactorsRodentiaInfectious disease modelingIxodesMachine-learningTBETBEVTBE virusTick-borne encephalitis

Identifiers

PMID40087786
PMCPMC11908066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.